Peter Thaddeus Gallagher

This inventor holds 34 USPTO granted patents and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Eli Lilly and Company, Lilly Industries, Inc.. Active years: 1990-2017.

USPTO Granted Patents = 34

% Patents Active = 52.9

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 110(Granted Patents)

Location History:

Camberley, GB (1990 - 1998)
Surrey, GB (2008)
Hampshire, GB (2005 - 2012)
Basingstoke, GB (2006 - 2012)
Yateley, GB (1991 - 2017)

Company Filing History:

28 out of 4,508

Eli Lilly and Company

patents

9 out of 158

Lilly Industries, Inc.

patents

where one patent can have more than one assignee

Years Active: 1990-2017

Loading Chart...

Areas of Expertise:

5-HT7 Receptor Antagonists

Monoamine Uptake Inhibitors

Norepinephrine Reuptake Inhibitors

Serotonin Reuptake Inhibitors

Piperidine Derivatives

Indole Compounds

Phenyl Amide Compounds

Therapy for Diabetic Complications

Heteroaryloxy Propanamines

Morpholine Derivatives

Aminopropyl Compounds

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9562057 - [object Object] (2017-02-07),

2. 8314092 - [object Object] (2012-11-20),

3. 8202873 - 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists (2012-06-19),

4. 7910588 - 5-HT7 receptor antagonists (2011-03-22),

5. 7619096 - 3-Aminopyrrolidines as inhibitors of monoamine uptake (2009-11-17),

6. 7615648 - Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake (2009-11-10),

7. 7595315 - Morpholine derivatives as norepinephrine reuptake inhibitors (2009-09-29),

8. 7521462 - 4-Amino-piperidine derivatives as monoamine uptake inhibitors (2009-04-21),

9. 7488728 - Pyridinylmorpholine derivatives (2009-02-10),

10. 7432280 - 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake (2008-10-07),

11. 7417064 - 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake (2008-08-26),

12. 7410996 - 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake (2008-08-12),

13. 7410982 - Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors (2008-08-12),

14. 7384941 - 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors (2008-06-10),

15. 7294623 - Benzyl morpholine derivatives (2007-11-13),

Title: Peter Thaddeus Gallagher: Pioneering Inventor from Basingstoke

Introduction: Peter Thaddeus Gallagher is a renowned inventor hailing from Basingstoke, Great Britain, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Gallagher's latest patents include a revolutionary design for a sustainable energy storage system and a cutting-edge medical device aimed at improving patient care and outcomes.

Career Highlights: With a career spanning over two decades, Gallagher has established himself as a leading figure in the world of innovation, holding numerous patents in areas such as renewable energy, healthcare technology, and consumer electronics.

Collaborations: Throughout his career, Peter Thaddeus Gallagher has collaborated with top research institutions, leading companies, and talented inventors worldwide, fostering a culture of creativity and excellence in all his projects.

Conclusion: Peter Thaddeus Gallagher's relentless pursuit of innovation and his passion for creating solutions to real-world problems have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.